0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Novel Drug Delivery Systems Market Size, Status and Forecast 2022
Published Date: January 2022
|
Report Code: QYRE-Auto-30X82
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global Novel Drug Delivery Systems Market Size Status and Forecast 2022

Global Novel Drug Delivery Systems Market Size, Status and Forecast 2022

Code: QYRE-Auto-30X82
Report
January 2022
129 Pages
QYResearch
Region: Global, North America, Europe, Central & South America, Middle East, Africa, Asia Pacific,
Description
Table of Content
Tables & Figures
Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms.
Advantages of Novel Drug Delivery System are: Optimum dose at the right time and right location, efficient use of expensive drugs, excipients and reduction in production cost, Beneficial to patients, better therapy, improved comfort and standard of living.
Global Novel Drug Delivery Systems key players include Amgen, Teva, Roche, UCB (Union Chimique Belge), etc. Global top four manufacturers hold a share over 40%.
North America is the largest market, with a share about 50%, followed by Asia-Pacific and Europe, both have a share over 40 percent.
In terms of product, PEGylated Proteins & Polypeptides is the largest segment, with a share about 40%. And in terms of application, the largest application is Hospitals & Clinic, followed by Cancer Treatment Centers, etc.
Market Analysis and Insights: Global Novel Drug Delivery Systems Market

The global Novel Drug Delivery Systems market size is projected to reach US$ 26880 million by 2027, from US$ 24110 million in 2020, at a CAGR of 1.7% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Novel Drug Delivery Systems market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Novel Drug Delivery Systems market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Novel Drug Delivery Systems market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Novel Drug Delivery Systems market.
Global Novel Drug Delivery Systems Scope and Market Size
Novel Drug Delivery Systems market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Novel Drug Delivery Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

Liposomes
PEGylated Proteins & Polypeptides
Polymer Nanoparticle
Protein–drug Conjugates
Others

Segment by Application

Hospitals & Clinic
Cancer Treatment Centers
Others

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

BY COMPANY

Amgen
Teva
Roche
UCB (Union Chimique Belge)
Celgene
Merck
Gilead Sciences
Sanofi
Pfizer
Takeda
Bausch&Lomb
Samyang Biopharmaceuticals
Johnson & Johnson
TOLMAR
Astellas
AMAG Pharmaceuticals
AbbVie
Dr Reddy
AstraZeneca
Aspen
Acrotech Biopharma
TWi Pharmaceuticals
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Novel Drug Delivery Systems Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Liposomes
1.2.3 PEGylated Proteins & Polypeptides
1.2.4 Polymer Nanoparticle
1.2.5 Protein–drug Conjugates
1.2.6 Others
1.3 Market by Application
1.3.1 Global Novel Drug Delivery Systems Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals & Clinic
1.3.3 Cancer Treatment Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Novel Drug Delivery Systems Market Perspective (2016-2027)
2.2 Novel Drug Delivery Systems Growth Trends by Regions
2.2.1 Novel Drug Delivery Systems Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Novel Drug Delivery Systems Historic Market Share by Regions (2016-2021)
2.2.3 Novel Drug Delivery Systems Forecasted Market Size by Regions (2022-2027)
2.3 Novel Drug Delivery Systems Industry Dynamic
2.3.1 Novel Drug Delivery Systems Market Trends
2.3.2 Novel Drug Delivery Systems Market Drivers
2.3.3 Novel Drug Delivery Systems Market Challenges
2.3.4 Novel Drug Delivery Systems Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Novel Drug Delivery Systems Players by Revenue
3.1.1 Global Top Novel Drug Delivery Systems Players by Revenue (2016-2021)
3.1.2 Global Novel Drug Delivery Systems Revenue Market Share by Players (2016-2021)
3.2 Global Novel Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Novel Drug Delivery Systems Revenue
3.4 Global Novel Drug Delivery Systems Market Concentration Ratio
3.4.1 Global Novel Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Novel Drug Delivery Systems Revenue in 2020
3.5 Novel Drug Delivery Systems Key Players Head office and Area Served
3.6 Key Players Novel Drug Delivery Systems Product Solution and Service
3.7 Date of Enter into Novel Drug Delivery Systems Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Novel Drug Delivery Systems Breakdown Data by Type
4.1 Global Novel Drug Delivery Systems Historic Market Size by Type (2016-2021)
4.2 Global Novel Drug Delivery Systems Forecasted Market Size by Type (2022-2027)
5 Novel Drug Delivery Systems Breakdown Data by Application
5.1 Global Novel Drug Delivery Systems Historic Market Size by Application (2016-2021)
5.2 Global Novel Drug Delivery Systems Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Novel Drug Delivery Systems Market Size (2016-2027)
6.2 North America Novel Drug Delivery Systems Market Size by Type
6.2.1 North America Novel Drug Delivery Systems Market Size by Type (2016-2021)
6.2.2 North America Novel Drug Delivery Systems Market Size by Type (2022-2027)
6.2.3 North America Novel Drug Delivery Systems Market Size by Type (2016-2027)
6.3 North America Novel Drug Delivery Systems Market Size by Application
6.3.1 North America Novel Drug Delivery Systems Market Size by Application (2016-2021)
6.3.2 North America Novel Drug Delivery Systems Market Size by Application (2022-2027)
6.3.3 North America Novel Drug Delivery Systems Market Size by Application (2016-2027)
6.4 North America Novel Drug Delivery Systems Market Size by Country
6.4.1 North America Novel Drug Delivery Systems Market Size by Country (2016-2021)
6.4.2 North America Novel Drug Delivery Systems Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Novel Drug Delivery Systems Market Size (2016-2027)
7.2 Europe Novel Drug Delivery Systems Market Size by Type
7.2.1 Europe Novel Drug Delivery Systems Market Size by Type (2016-2021)
7.2.2 Europe Novel Drug Delivery Systems Market Size by Type (2022-2027)
7.2.3 Europe Novel Drug Delivery Systems Market Size by Type (2016-2027)
7.3 Europe Novel Drug Delivery Systems Market Size by Application
7.3.1 Europe Novel Drug Delivery Systems Market Size by Application (2016-2021)
7.3.2 Europe Novel Drug Delivery Systems Market Size by Application (2022-2027)
7.3.3 Europe Novel Drug Delivery Systems Market Size by Application (2016-2027)
7.4 Europe Novel Drug Delivery Systems Market Size by Country
7.4.1 Europe Novel Drug Delivery Systems Market Size by Country (2016-2021)
7.4.2 Europe Novel Drug Delivery Systems Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Novel Drug Delivery Systems Market Size (2016-2027)
8.2 Asia-Pacific Novel Drug Delivery Systems Market Size by Type
8.2.1 Asia-Pacific Novel Drug Delivery Systems Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Novel Drug Delivery Systems Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Novel Drug Delivery Systems Market Size by Type (2016-2027)
8.3 Asia-Pacific Novel Drug Delivery Systems Market Size by Application
8.3.1 Asia-Pacific Novel Drug Delivery Systems Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Novel Drug Delivery Systems Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Novel Drug Delivery Systems Market Size by Application (2016-2027)
8.4 Asia-Pacific Novel Drug Delivery Systems Market Size by Region
8.4.1 Asia-Pacific Novel Drug Delivery Systems Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Novel Drug Delivery Systems Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Novel Drug Delivery Systems Market Size (2016-2027)
9.2 Latin America Novel Drug Delivery Systems Market Size by Type
9.2.1 Latin America Novel Drug Delivery Systems Market Size by Type (2016-2021)
9.2.2 Latin America Novel Drug Delivery Systems Market Size by Type (2022-2027)
9.2.3 Latin America Novel Drug Delivery Systems Market Size by Type (2016-2027)
9.3 Latin America Novel Drug Delivery Systems Market Size by Application
9.3.1 Latin America Novel Drug Delivery Systems Market Size by Application (2016-2021)
9.3.2 Latin America Novel Drug Delivery Systems Market Size by Application (2022-2027)
9.3.3 Latin America Novel Drug Delivery Systems Market Size by Application (2016-2027)
9.4 Latin America Novel Drug Delivery Systems Market Size by Country
9.4.1 Latin America Novel Drug Delivery Systems Market Size by Country (2016-2021)
9.4.2 Latin America Novel Drug Delivery Systems Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Novel Drug Delivery Systems Market Size (2016-2027)
10.2 Middle East & Africa Novel Drug Delivery Systems Market Size by Type
10.2.1 Middle East & Africa Novel Drug Delivery Systems Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Novel Drug Delivery Systems Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Novel Drug Delivery Systems Market Size by Type (2016-2027)
10.3 Middle East & Africa Novel Drug Delivery Systems Market Size by Application
10.3.1 Middle East & Africa Novel Drug Delivery Systems Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Novel Drug Delivery Systems Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Novel Drug Delivery Systems Market Size by Application (2016-2027)
10.4 Middle East & Africa Novel Drug Delivery Systems Market Size by Country
10.4.1 Middle East & Africa Novel Drug Delivery Systems Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Novel Drug Delivery Systems Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Novel Drug Delivery Systems Introduction
11.1.4 Amgen Revenue in Novel Drug Delivery Systems Business (2016-2021)
11.1.5 Amgen Recent Development
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Teva Business Overview
11.2.3 Teva Novel Drug Delivery Systems Introduction
11.2.4 Teva Revenue in Novel Drug Delivery Systems Business (2016-2021)
11.2.5 Teva Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Novel Drug Delivery Systems Introduction
11.3.4 Roche Revenue in Novel Drug Delivery Systems Business (2016-2021)
11.3.5 Roche Recent Development
11.4 UCB (Union Chimique Belge)
11.4.1 UCB (Union Chimique Belge) Company Details
11.4.2 UCB (Union Chimique Belge) Business Overview
11.4.3 UCB (Union Chimique Belge) Novel Drug Delivery Systems Introduction
11.4.4 UCB (Union Chimique Belge) Revenue in Novel Drug Delivery Systems Business (2016-2021)
11.4.5 UCB (Union Chimique Belge) Recent Development
11.5 Celgene
11.5.1 Celgene Company Details
11.5.2 Celgene Business Overview
11.5.3 Celgene Novel Drug Delivery Systems Introduction
11.5.4 Celgene Revenue in Novel Drug Delivery Systems Business (2016-2021)
11.5.5 Celgene Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Novel Drug Delivery Systems Introduction
11.6.4 Merck Revenue in Novel Drug Delivery Systems Business (2016-2021)
11.6.5 Merck Recent Development
11.7 Gilead Sciences
11.7.1 Gilead Sciences Company Details
11.7.2 Gilead Sciences Business Overview
11.7.3 Gilead Sciences Novel Drug Delivery Systems Introduction
11.7.4 Gilead Sciences Revenue in Novel Drug Delivery Systems Business (2016-2021)
11.7.5 Gilead Sciences Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Novel Drug Delivery Systems Introduction
11.8.4 Sanofi Revenue in Novel Drug Delivery Systems Business (2016-2021)
11.8.5 Sanofi Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Novel Drug Delivery Systems Introduction
11.9.4 Pfizer Revenue in Novel Drug Delivery Systems Business (2016-2021)
11.9.5 Pfizer Recent Development
11.10 Takeda
11.10.1 Takeda Company Details
11.10.2 Takeda Business Overview
11.10.3 Takeda Novel Drug Delivery Systems Introduction
11.10.4 Takeda Revenue in Novel Drug Delivery Systems Business (2016-2021)
11.10.5 Takeda Recent Development
11.11 Bausch&Lomb
11.11.1 Bausch&Lomb Company Details
11.11.2 Bausch&Lomb Business Overview
11.11.3 Bausch&Lomb Novel Drug Delivery Systems Introduction
11.11.4 Bausch&Lomb Revenue in Novel Drug Delivery Systems Business (2016-2021)
11.11.5 Bausch&Lomb Recent Development
11.12 Samyang Biopharmaceuticals
11.12.1 Samyang Biopharmaceuticals Company Details
11.12.2 Samyang Biopharmaceuticals Business Overview
11.12.3 Samyang Biopharmaceuticals Novel Drug Delivery Systems Introduction
11.12.4 Samyang Biopharmaceuticals Revenue in Novel Drug Delivery Systems Business (2016-2021)
11.12.5 Samyang Biopharmaceuticals Recent Development
11.13 Johnson & Johnson
11.13.1 Johnson & Johnson Company Details
11.13.2 Johnson & Johnson Business Overview
11.13.3 Johnson & Johnson Novel Drug Delivery Systems Introduction
11.13.4 Johnson & Johnson Revenue in Novel Drug Delivery Systems Business (2016-2021)
11.13.5 Johnson & Johnson Recent Development
11.14 TOLMAR
11.14.1 TOLMAR Company Details
11.14.2 TOLMAR Business Overview
11.14.3 TOLMAR Novel Drug Delivery Systems Introduction
11.14.4 TOLMAR Revenue in Novel Drug Delivery Systems Business (2016-2021)
11.14.5 TOLMAR Recent Development
11.15 Astellas
11.15.1 Astellas Company Details
11.15.2 Astellas Business Overview
11.15.3 Astellas Novel Drug Delivery Systems Introduction
11.15.4 Astellas Revenue in Novel Drug Delivery Systems Business (2016-2021)
11.15.5 Astellas Recent Development
11.16 AMAG Pharmaceuticals
11.16.1 AMAG Pharmaceuticals Company Details
11.16.2 AMAG Pharmaceuticals Business Overview
11.16.3 AMAG Pharmaceuticals Novel Drug Delivery Systems Introduction
11.16.4 AMAG Pharmaceuticals Revenue in Novel Drug Delivery Systems Business (2016-2021)
11.16.5 AMAG Pharmaceuticals Recent Development
11.17 AbbVie
11.17.1 AbbVie Company Details
11.17.2 AbbVie Business Overview
11.17.3 AbbVie Novel Drug Delivery Systems Introduction
11.17.4 AbbVie Revenue in Novel Drug Delivery Systems Business (2016-2021)
11.17.5 AbbVie Recent Development
11.18 Dr Reddy
11.18.1 Dr Reddy Company Details
11.18.2 Dr Reddy Business Overview
11.18.3 Dr Reddy Novel Drug Delivery Systems Introduction
11.18.4 Dr Reddy Revenue in Novel Drug Delivery Systems Business (2016-2021)
11.18.5 Dr Reddy Recent Development
11.19 AstraZeneca
11.19.1 AstraZeneca Company Details
11.19.2 AstraZeneca Business Overview
11.19.3 AstraZeneca Novel Drug Delivery Systems Introduction
11.19.4 AstraZeneca Revenue in Novel Drug Delivery Systems Business (2016-2021)
11.19.5 AstraZeneca Recent Development
11.20 Aspen
11.20.1 Aspen Company Details
11.20.2 Aspen Business Overview
11.20.3 Aspen Novel Drug Delivery Systems Introduction
11.20.4 Aspen Revenue in Novel Drug Delivery Systems Business (2016-2021)
11.20.5 Aspen Recent Development
11.21 Acrotech Biopharma
11.21.1 Acrotech Biopharma Company Details
11.21.2 Acrotech Biopharma Business Overview
11.21.3 Acrotech Biopharma Novel Drug Delivery Systems Introduction
11.21.4 Acrotech Biopharma Revenue in Novel Drug Delivery Systems Business (2016-2021)
11.21.5 Acrotech Biopharma Recent Development
11.22 TWi Pharmaceuticals
11.22.1 TWi Pharmaceuticals Company Details
11.22.2 TWi Pharmaceuticals Business Overview
11.22.3 TWi Pharmaceuticals Novel Drug Delivery Systems Introduction
11.22.4 TWi Pharmaceuticals Revenue in Novel Drug Delivery Systems Business (2016-2021)
11.22.5 TWi Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Novel Drug Delivery Systems Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Liposomes
    Table 3. Key Players of PEGylated Proteins & Polypeptides
    Table 4. Key Players of Polymer Nanoparticle
    Table 5. Key Players of Protein–drug Conjugates
    Table 6. Key Players of Others
    Table 7. Global Novel Drug Delivery Systems Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Novel Drug Delivery Systems Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Novel Drug Delivery Systems Market Size by Regions (2016-2021) & (US$ Million)
    Table 10. Global Novel Drug Delivery Systems Market Share by Regions (2016-2021)
    Table 11. Global Novel Drug Delivery Systems Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 12. Global Novel Drug Delivery Systems Market Share by Regions (2022-2027)
    Table 13. Novel Drug Delivery Systems Market Trends
    Table 14. Novel Drug Delivery Systems Market Drivers
    Table 15. Novel Drug Delivery Systems Market Challenges
    Table 16. Novel Drug Delivery Systems Market Restraints
    Table 17. Global Novel Drug Delivery Systems Revenue by Players (2016-2021) & (US$ Million)
    Table 18. Global Novel Drug Delivery Systems Market Share by Players (2016-2021)
    Table 19. Global Top Novel Drug Delivery Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Novel Drug Delivery Systems as of 2020)
    Table 20. Ranking of Global Top Novel Drug Delivery Systems Companies by Revenue (US$ Million) in 2020
    Table 21. Global 5 Largest Players Market Share by Novel Drug Delivery Systems Revenue (CR5 and HHI) & (2016-2021)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Novel Drug Delivery Systems Product Solution and Service
    Table 24. Date of Enter into Novel Drug Delivery Systems Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Novel Drug Delivery Systems Market Size by Type (2016-2021) (US$ Million)
    Table 27. Global Novel Drug Delivery Systems Revenue Market Share by Type (2016-2021)
    Table 28. Global Novel Drug Delivery Systems Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 29. Global Novel Drug Delivery Systems Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 30. Global Novel Drug Delivery Systems Market Size Share by Application (2016-2021) & (US$ Million)
    Table 31. Global Novel Drug Delivery Systems Revenue Market Share by Application (2016-2021)
    Table 32. Global Novel Drug Delivery Systems Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 33. Global Novel Drug Delivery Systems Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 34. North America Novel Drug Delivery Systems Market Size by Type (2016-2021) (US$ Million)
    Table 35. North America Novel Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million)
    Table 36. North America Novel Drug Delivery Systems Market Size by Application (2016-2021) (US$ Million)
    Table 37. North America Novel Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million)
    Table 38. North America Novel Drug Delivery Systems Market Size by Country (2016-2021) & (US$ Million)
    Table 39. North America Novel Drug Delivery Systems Market Size by Country (2022-2027) & (US$ Million)
    Table 40. Europe Novel Drug Delivery Systems Market Size by Type (2016-2021) (US$ Million)
    Table 41. Europe Novel Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million)
    Table 42. Europe Novel Drug Delivery Systems Market Size by Application (2016-2021) (US$ Million)
    Table 43. Europe Novel Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million)
    Table 44. Europe Novel Drug Delivery Systems Market Size by Country (2016-2021) & (US$ Million)
    Table 45. Europe Novel Drug Delivery Systems Market Size by Country (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Novel Drug Delivery Systems Market Size by Type (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Novel Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Novel Drug Delivery Systems Market Size by Application (2016-2021) (US$ Million)
    Table 49. Asia-Pacific Novel Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific Novel Drug Delivery Systems Market Size by Region (2016-2021) & (US$ Million)
    Table 51. Asia-Pacific Novel Drug Delivery Systems Market Size by Region (2022-2027) & (US$ Million)
    Table 52. Latin America Novel Drug Delivery Systems Market Size by Type (2016-2021) (US$ Million)
    Table 53. Latin America Novel Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million)
    Table 54. Latin America Novel Drug Delivery Systems Market Size by Application (2016-2021) (US$ Million)
    Table 55. Latin America Novel Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million)
    Table 56. Latin America Novel Drug Delivery Systems Market Size by Country (2016-2021) & (US$ Million)
    Table 57. Latin America Novel Drug Delivery Systems Market Size by Country (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Novel Drug Delivery Systems Market Size by Type (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Novel Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Novel Drug Delivery Systems Market Size by Application (2016-2021) (US$ Million)
    Table 61. Middle East & Africa Novel Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa Novel Drug Delivery Systems Market Size by Country (2016-2021) & (US$ Million)
    Table 63. Middle East & Africa Novel Drug Delivery Systems Market Size by Country (2022-2027) & (US$ Million)
    Table 64. Amgen Company Details
    Table 65. Amgen Business Overview
    Table 66. Amgen Novel Drug Delivery Systems Product
    Table 67. Amgen Revenue in Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 68. Amgen Recent Development
    Table 69. Teva Company Details
    Table 70. Teva Business Overview
    Table 71. Teva Novel Drug Delivery Systems Product
    Table 72. Teva Revenue in Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 73. Teva Recent Development
    Table 74. Roche Company Details
    Table 75. Roche Business Overview
    Table 76. Roche Novel Drug Delivery Systems Product
    Table 77. Roche Revenue in Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 78. Roche Recent Development
    Table 79. UCB (Union Chimique Belge) Company Details
    Table 80. UCB (Union Chimique Belge) Business Overview
    Table 81. UCB (Union Chimique Belge) Novel Drug Delivery Systems Product
    Table 82. UCB (Union Chimique Belge) Revenue in Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 83. UCB (Union Chimique Belge) Recent Development
    Table 84. Celgene Company Details
    Table 85. Celgene Business Overview
    Table 86. Celgene Novel Drug Delivery Systems Product
    Table 87. Celgene Revenue in Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 88. Celgene Recent Development
    Table 89. Merck Company Details
    Table 90. Merck Business Overview
    Table 91. Merck Novel Drug Delivery Systems Product
    Table 92. Merck Revenue in Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 93. Merck Recent Development
    Table 94. Gilead Sciences Company Details
    Table 95. Gilead Sciences Business Overview
    Table 96. Gilead Sciences Novel Drug Delivery Systems Product
    Table 97. Gilead Sciences Revenue in Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 98. Gilead Sciences Recent Development
    Table 99. Sanofi Company Details
    Table 100. Sanofi Business Overview
    Table 101. Sanofi Revenue in Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 102. Sanofi Recent Development
    Table 103. Pfizer Company Details
    Table 104. Pfizer Business Overview
    Table 105. Pfizer Novel Drug Delivery Systems Product
    Table 106. Pfizer Revenue in Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 107. Pfizer Recent Development
    Table 108. Takeda Company Details
    Table 109. Takeda Business Overview
    Table 110. Takeda Novel Drug Delivery Systems Product
    Table 111. Takeda Revenue in Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 112. Takeda Recent Development
    Table 113. Bausch&Lomb Company Details
    Table 114. Bausch&Lomb Business Overview
    Table 115. Bausch&Lomb Novel Drug Delivery Systems Product
    Table 116. Bausch&Lomb Revenue in Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 117. Bausch&Lomb Recent Development
    Table 118. Samyang Biopharmaceuticals Company Details
    Table 119. Samyang Biopharmaceuticals Business Overview
    Table 120. Samyang Biopharmaceuticals Novel Drug Delivery Systems Product
    Table 121. Samyang Biopharmaceuticals Revenue in Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 122. Samyang Biopharmaceuticals Recent Development
    Table 123. Johnson & Johnson Company Details
    Table 124. Johnson & Johnson Business Overview
    Table 125. Johnson & Johnson Novel Drug Delivery Systems Product
    Table 126. Johnson & Johnson Revenue in Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 127. Johnson & Johnson Recent Development
    Table 128. TOLMAR Company Details
    Table 129. TOLMAR Business Overview
    Table 130. TOLMAR Novel Drug Delivery Systems Product
    Table 131. TOLMAR Revenue in Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 132. TOLMAR Recent Development
    Table 133. Astellas Company Details
    Table 134. Astellas Business Overview
    Table 135. Astellas Novel Drug Delivery Systems Product
    Table 136. Astellas Revenue in Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 137. Astellas Recent Development
    Table 138. AMAG Pharmaceuticals Company Details
    Table 139. AMAG Pharmaceuticals Business Overview
    Table 140. AMAG Pharmaceuticals Novel Drug Delivery Systems Product
    Table 141. AMAG Pharmaceuticals Revenue in Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 142. AMAG Pharmaceuticals Recent Development
    Table 143. AbbVie Company Details
    Table 144. AbbVie Business Overview
    Table 145. AbbVie Novel Drug Delivery Systems Product
    Table 146. AbbVie Revenue in Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 147. AbbVie Recent Development
    Table 148. Dr Reddy Company Details
    Table 149. Dr Reddy Business Overview
    Table 150. Dr Reddy Novel Drug Delivery Systems Product
    Table 151. Dr Reddy Revenue in Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 152. Dr Reddy Recent Development
    Table 153. AstraZeneca Company Details
    Table 154. AstraZeneca Business Overview
    Table 155. AstraZeneca Novel Drug Delivery Systems Product
    Table 156. AstraZeneca Revenue in Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 157. AstraZeneca Recent Development
    Table 158. Aspen Company Details
    Table 159. Aspen Business Overview
    Table 160. Aspen Novel Drug Delivery Systems Product
    Table 161. Aspen Revenue in Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 162. Aspen Recent Development
    Table 163. Acrotech Biopharma Company Details
    Table 164. Acrotech Biopharma Business Overview
    Table 165. Acrotech Biopharma Novel Drug Delivery Systems Product
    Table 166. Acrotech Biopharma Revenue in Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 167. Acrotech Biopharma Recent Development
    Table 168. TWi Pharmaceuticals Company Details
    Table 169. TWi Pharmaceuticals Business Overview
    Table 170. TWi Pharmaceuticals Novel Drug Delivery Systems Product
    Table 171. TWi Pharmaceuticals Revenue in Novel Drug Delivery Systems Business (2016-2021) & (US$ Million)
    Table 172. TWi Pharmaceuticals Recent Development
    Table 173. Research Programs/Design for This Report
    Table 174. Key Data Information from Secondary Sources
    Table 175. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Novel Drug Delivery Systems Market Share by Type: 2020 VS 2027
    Figure 2. Liposomes Features
    Figure 3. PEGylated Proteins & Polypeptides Features
    Figure 4. Polymer Nanoparticle Features
    Figure 5. Protein–drug Conjugates Features
    Figure 6. Others Features
    Figure 7. Global Novel Drug Delivery Systems Market Share by Application: 2020 VS 2027
    Figure 8. Hospitals & Clinic Case Studies
    Figure 9. Cancer Treatment Centers Case Studies
    Figure 10. Others Case Studies
    Figure 11. Novel Drug Delivery Systems Report Years Considered
    Figure 12. Global Novel Drug Delivery Systems Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 13. Global Novel Drug Delivery Systems Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global Novel Drug Delivery Systems Market Share by Regions: 2020 VS 2027
    Figure 15. Global Novel Drug Delivery Systems Market Share by Regions (2022-2027)
    Figure 16. Global Novel Drug Delivery Systems Market Share by Players in 2020
    Figure 17. Global Top Novel Drug Delivery Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Novel Drug Delivery Systems as of 2020
    Figure 18. The Top 10 and 5 Players Market Share by Novel Drug Delivery Systems Revenue in 2020
    Figure 19. Global Novel Drug Delivery Systems Revenue Market Share by Type (2016-2021)
    Figure 20. Global Novel Drug Delivery Systems Revenue Market Share by Type (2022-2027)
    Figure 21. North America Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. North America Novel Drug Delivery Systems Market Share by Type (2016-2027)
    Figure 23. North America Novel Drug Delivery Systems Market Share by Application (2016-2027)
    Figure 24. North America Novel Drug Delivery Systems Market Share by Country (2016-2027)
    Figure 25. United States Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Canada Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Novel Drug Delivery Systems Market Share by Type (2016-2027)
    Figure 29. Europe Novel Drug Delivery Systems Market Share by Application (2016-2027)
    Figure 30. Europe Novel Drug Delivery Systems Market Share by Country (2016-2027)
    Figure 31. Germany Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. France Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. U.K. Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Italy Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Russia Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Nordic Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Novel Drug Delivery Systems Market Share by Type (2016-2027)
    Figure 39. Asia-Pacific Novel Drug Delivery Systems Market Share by Application (2016-2027)
    Figure 40. Asia-Pacific Novel Drug Delivery Systems Market Share by Region (2016-2027)
    Figure 41. China Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Japan Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. South Korea Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Southeast Asia Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. India Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Australia Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Novel Drug Delivery Systems Market Share by Type (2016-2027)
    Figure 49. Latin America Novel Drug Delivery Systems Market Share by Application (2016-2027)
    Figure 50. Latin America Novel Drug Delivery Systems Market Share by Country (2016-2027)
    Figure 51. Mexico Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Brazil Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Novel Drug Delivery Systems Market Share by Type (2016-2027)
    Figure 55. Middle East & Africa Novel Drug Delivery Systems Market Share by Application (2016-2027)
    Figure 56. Middle East & Africa Novel Drug Delivery Systems Market Share by Country (2016-2027)
    Figure 57. Turkey Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Saudi Arabia Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. UAE Novel Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Amgen Revenue Growth Rate in Novel Drug Delivery Systems Business (2016-2021)
    Figure 61. Teva Revenue Growth Rate in Novel Drug Delivery Systems Business (2016-2021)
    Figure 62. Roche Revenue Growth Rate in Novel Drug Delivery Systems Business (2016-2021)
    Figure 63. UCB (Union Chimique Belge) Revenue Growth Rate in Novel Drug Delivery Systems Business (2016-2021)
    Figure 64. Celgene Revenue Growth Rate in Novel Drug Delivery Systems Business (2016-2021)
    Figure 65. Merck Revenue Growth Rate in Novel Drug Delivery Systems Business (2016-2021)
    Figure 66. Gilead Sciences Revenue Growth Rate in Novel Drug Delivery Systems Business (2016-2021)
    Figure 67. Sanofi Revenue Growth Rate in Novel Drug Delivery Systems Business (2016-2021)
    Figure 68. Pfizer Revenue Growth Rate in Novel Drug Delivery Systems Business (2016-2021)
    Figure 69. Takeda Revenue Growth Rate in Novel Drug Delivery Systems Business (2016-2021)
    Figure 70. Bausch&Lomb Revenue Growth Rate in Novel Drug Delivery Systems Business (2016-2021)
    Figure 71. Samyang Biopharmaceuticals Revenue Growth Rate in Novel Drug Delivery Systems Business (2016-2021)
    Figure 72. Johnson & Johnson Revenue Growth Rate in Novel Drug Delivery Systems Business (2016-2021)
    Figure 73. TOLMAR Revenue Growth Rate in Novel Drug Delivery Systems Business (2016-2021)
    Figure 74. Astellas Revenue Growth Rate in Novel Drug Delivery Systems Business (2016-2021)
    Figure 75. AMAG Pharmaceuticals Revenue Growth Rate in Novel Drug Delivery Systems Business (2016-2021)
    Figure 76. AbbVie Revenue Growth Rate in Novel Drug Delivery Systems Business (2016-2021)
    Figure 77. Dr Reddy Revenue Growth Rate in Novel Drug Delivery Systems Business (2016-2021)
    Figure 78. AstraZeneca Revenue Growth Rate in Novel Drug Delivery Systems Business (2016-2021)
    Figure 79. Aspen Revenue Growth Rate in Novel Drug Delivery Systems Business (2016-2021)
    Figure 80. Acrotech Biopharma Revenue Growth Rate in Novel Drug Delivery Systems Business (2016-2021)
    Figure 81. TWi Pharmaceuticals Revenue Growth Rate in Novel Drug Delivery Systems Business (2016-2021)
    Figure 82. Bottom-up and Top-down Approaches for This Report
    Figure 83. Data Triangulation
    Figure 84. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Accenture

RELATED REPORTS

Global GC and GC MS Market Insights and Forecast to 2028
Global GC and GC-MS Market Insights and Forecast to 2028

Chromatography is a technique for separating chemical substances that relies on differences in partitioning behaviour between a flowing mobile phase and a stationary phase to separate the components in a mixture.Market Analysis and Insights Global GC and GCMS MarketDue to the COVID19 pandemic the global GC and GCMS market size is estimated to be worth US 1609.2 million in 2022 and is forecast to a readjusted size of US 2144.2 million by 2028 with a CAGR of 4.9 during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-7K9415
Sun Jan 09 00:00:00 UTC 2022

Add to Cart

Global Oxaliplatin Market Insights and Forecast to 2028
Global Oxaliplatin Market Insights and Forecast to 2028

It is often used for metastatic colorectal cancer treatment or adjuvant therapy the third stage colon cancer after resecting primary tumor completely.In this report only the finished drug is covered exclude API.Market Analysis and Insights Global Oxaliplatin MarketThe global Oxaliplatin market size is projected to reach US 1641.5 million by 2028 from US 897.5 million in 2021 at a CAGR of 8.9 during 20222028.Europe is the largest market with about 33 market share.

120 Pages
Type: Report
Code: QYRE-Auto-5N9258
Sun Jan 09 00:00:00 UTC 2022

Add to Cart

Global Antibody drug Conjugates Market Insights and Forecast to 2028
Global Antibody-drug Conjugates Market Insights and Forecast to 2028

By combining the unique targeting of mAbs with the cancerkilling ability of cytotoxic drugs ADCs allow sensitive discrimination between healthy and diseased tissue.Market Analysis and Insights Global Antibodydrug Conjugates MarketDue to the COVID19 pandemic the global Antibodydrug Conjugates market size is estimated to be worth US 2975.7 million in 2022 and is forecast to a readjusted size of US 3919.8 million by 2028 with a CAGR of 4.7 during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-31N9042
Sun Jan 09 00:00:00 UTC 2022

Add to Cart

Global MALDI TOF Mass Spectrometer Market Insights and Forecast to 2028
Global MALDI-TOF Mass Spectrometer Market Insights and Forecast to 2028

While Biopharmaceuticals Companies segment is altered to an CAGR throughout this forecast period.Global MALDITOF Mass Spectrometer Market Insights and Forecast to 2028.

120 Pages
Type: Report
Code: QYRE-Auto-4S9413
Sun Jan 09 00:00:00 UTC 2022

Add to Cart